Current Laboratory Member

Gordon K Chan, Ph.D. Principal Investigator
Cody Lewis, B.Sc., M.Sc. Ph.D. student
Joanne D. Smith, B.Sc. M.Sc. student
Abigail Linares Cruz, B.Sc. M.Sc. student
Kaushiki Roy, B. Tech, M. Tech Ph.D. student (visiting)
Sargun Sokhi Undergraduate research project student
Ling Xie, Ph.D. Visiting scholar (Associate Professor, Hunan Agricultural University, China)


Research Interests - Overview

In my laboratory, research is centered on the mechanism of cell cycle control and particularly the regulation of accurate chromosome segregation during mitosis. The mitotic checkpoint is a failsafe mechanism by which the cell prevents premature anaphase and ensures accurate chromosome segregation. The relevance this line of basic research to cancer is established in the demonstrated importance of chromosome fidelity during cell division to carcinogenesis. By investigating the molecular mechanism of the mitotic checkpoint, we can better evaluate these genes as potential cancer drug targets as well as contributing to the basic understanding of cancer.
 


Ongoing Research Highlights

We have three main areas of research: (i) the role(s) of the RZZ complex in mitotic checkpoint regulation and (ii) the role of the mitotic checkpoint in mitotic catastrophe (iii) cell cycle kinases Wee1 and Myt1 synthetic lethality in breast cancer.
(i) The RZZ complex consists of three proteins, Rod, Zw10 and Zwilch. They are kinetochore proteins that recruit the microtubule motor, dynein/dynactin, to kinetochores but were found to be also essential for the mitotic checkpoint. The RZZ complex is essential for the recruitment of the mitotic checkpoint effector Mad2 to kinetochores. The exact mechanism is still unknown. We are using molecular, biochemical and cell biological approaches to study the structure and function of the mitotic checkpoint apparatus in order to understand the underlying mechanism.
(ii) Mitotic catastrophe is a cell death phenomenon that has been observed, however, there is not a molecular marker and the mechanism of action is not known. We are following up on the findings that genotoxic treatments of cancer cells often result in checkpoint adaptation and ultimately mitotic catastrophe. We have observed that prolonged mitotic arrest and centromere fragmentation often accompany mitotic catastrophe. We are examining the role of the mitotic checkpoint in this cell death process.
(iii) Wee1 and Myt1 are cell cycle kinases that mediate inhibitory Cdk1 phosphorylation. In addition to being important for regulating the G2/M checkpoint, they are also essential for inhibiting Cdk1 activity at the end of mitosis. MK-1775 is a small molecule inhibitor of Wee1 kinase activity and is currently undergoing Phase I/II clinical trial for multiple cancers. We have identified the Myt1 kinase as a resistance factor for MK-1775 in breast cancers. We are examining the mechanism of Myt1 function in mediating MK-1775 resistance.


 
Recent Student Achievement

2019, Edric Xiao, Oncology Summer Student Presentation 1st place
2019,Sargun Sokhi, Oncology Summer Student Presentation 2nd place

E. XiaoS. Sokhi

2019, David He, Oncology Summer Student Presentation Honorable mention
2019, Edric Xiao is the recipient of the NSERC Undergraduate Student Research Award, the Alberta Innovate summer studentship (declined)
2019, Kaushiki Roy is the recipient of a India Science and Engineering Research Board (SERB) scholarship
2019, Joanne Smith is the recipient of the QEII studentship